Quince Therapeutics Inc (QNCX) Live Share Price, Invest From India

Quince Therapeutics Inc Stock Performance

as on March 14, 2026 at 6:59 am IST

Day's High
$0.10
Day's Price Range
$0.11
$0.10
10.00%
Upside
52 Week's Low
52 Week's High
$0.09
52-Week Price Range
$4.55
$0.10
12.00%
Downside
4449.90%
Upside

Quince Therapeutics Inc share price movements today

Previous Close: $0.11
Open: $0.10
Volume: 9.6M
Day's Low - High: $0.10 - $0.11
52 Week Low - High: $0.09 - $4.55

Quince Therapeutics Inc Historical Returns

1 Month Return: -46.75 %
3 Month Return: -97.12 %
1 Year Return: -92.6 %
3 Year Return: -87.32 %
5 Year Return: 0 %

Quince Therapeutics Inc Stock Fundamentals & Key Indicators

Check Quince Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.9M

EPS (TTM)

-1.155

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-41.7M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-247.78%

Quince Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Quince Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Quince Therapeutics Inc	SELL	$5.9M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$41.6B	117.98%	135.09	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$119.2B	114.32%	30.68	32.94%
Beone Medicines Ltd	NA	$32.8B	NA	115	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$78.8B	54.67%	17.99	31.41%

Stock Returns calculator for Quince Therapeutics Inc Stock including INR - Dollar returns

The Quince Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Quince Therapeutics Inc investment value today

Current value as on today

₹13,444

Returns

₹86,556

(-86.56%)

Returns from Quince Therapeutics Inc Stock

₹93,056 (-93.06%)

Dollar Returns*

₹6,499 (+6.5%)

Analyst Recommendation on Quince Therapeutics Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Quince Therapeutics Inc. Average target price of $5

Quince Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Quince Therapeutics Inc.

What analysts predicted

98%UPSIDE

Target Price

Current Price

$0.1

Analyzed by

6 Analysts

Target

$5.00

Quince Therapeutics Inc target price $5, a slight upside of 98% compared to current price of $0.1. According to 6 analysts rating.

Quince Therapeutics Inc Stock’s Investor Sentiment and Interest

Investment in Quince Therapeutics Inc Shares on INDmoney has dropped by -59.10% over the past 30 days, indicating reduced transactional activity.

Time period: February 14, 2026 to March 16, 2026

Change:-59.10% versus previous 30 day period

Search interest for Quince Therapeutics Inc Stock has increased by 166% in the last 30 days, reflecting an upward trend in search activity.

Time period: February 14, 2026 to March 16, 2026

Change:166% versus previous 30 day period

Quince Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	-	0	-	-	0	-	-	-
Gross Profit	0	-	-	0	0	0	0	0	0	0
Operating Income	-5	-6	-8	-11	-28	-5	-10	-14	-9	-11
EBITDA	-5	-6	-	-8	-8	-8	-12	-12	-15	-13
Interest Expense	-	-	-	0	-	-	2	-	-	-
Depreciation	0	-	0	0	0	0	0	0	0	0
Income Before Tax	-4	-5	-8	-11	-27	-5	-12	-14	-15	-13
Income Tax Expense	0	0	-	0	0	0	0	0	0	0
Net Income	-4	-5	-8	-11	-27	-5	-12	-15	-16	-13
Net Profit Margin	0.00%	0.00%	0.00%	-30969.44%	0.00%	0.00%	-7415.48%	0.00%	0.00%	0.00%

Quince Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0
Operating Income	-12	-39	-78	-90	-52	-34	-57
EBITDA	-12	-38	-78	-89	-50	-26	-35
Interest Expense	0	2	2	0	0	-	-
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-12	-36	-76	-89	-51	-31	-56
Income Tax Expense	0	0	2	0	0	0	0
Net Income	-12	-36	-76	-89	-51	-31	-56
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Quince Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-5	-8	-11	-27	-5	-12	-15	-16	-13
Operating Cash Flow	-4	-6	-8	-8	-7	-7	-9	-11	-9
Investing Cash Flow	3	-	8	-4	7	10	10	6	-1
Financing Cash Flow	0	0	0	0	-5	-	0	14	1
Change in Cash	-1	0	1	-13	-5	3	1	9	-10

Quince Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-12	-36	-76	-89	-51	-31	-56
Operating Cash Flow	-11	-33	-50	-62	-44	-18	-31
Investing Cash Flow	-46	-17	-52	58	18	-5	21
Financing Cash Flow	75	77	118	6	0	0	-4
Change in Cash	17	26	15	2	-25	-23	-14

Global Institutional Holdings in Quince Therapeutics Inc

Funds	Holdings
Vanguard Group Inc	3.74%
Millennium Management LLC	2.14%
StemPoint Capital LP	1.33%
Bridgeway Capital Management, LLC	0.17%
Marshall Wace Asset Management Ltd	0.38%

See all

Insights on Quince Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 29.6% return, outperforming this stock by 122.2%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 65.2% return, outperforming this stock by 152.5%
NEGATIVE IMPACT
Price Dip
In the last 1 month, QNCX stock has moved down by -46.8%

About Quince Therapeutics Inc

cortexyme is developing therapeutics based on data supporting a new theory of the cause of alzheimer's and other degenerative disorders. cortexyme is targeting a specific, undisclosed pathogen tied to neurodegeneration and beta amyloid production. the target has been validated in a number of animal models and cortexyme is currently moving a proprietary small molecule towards human clinical testing.

Organisation	Quince Therapeutics Inc
Headquarters	611 Gateway Boulevard, South San Francisco, CA, United States, 94080
Industry	Healthcare
CEO	Dr. Dirk Thye M.D.
E-voting on shares	Click here to vote

Key Management of Quince Therapeutics Inc

Name	Title
Dr. Dirk Thye M.D.	CEO, Chief Medical Officer & Director
Dr. Charles S. Ryan J.D., Ph.D.	President
Mr. Brendan Hannah M.B.A.	Chief Business Officer, COO, Chief Compliance Officer and Principal Financial & Accounting Officer
Mr. Giovanni Mambrini M.Sc.	Chief Technology Officer
Dr. Guenter R. Janhofer M.D., Ph.D.	Chief Scientific Officer
Dr. Stewart A. Low Ph.D.	Head of Discovery

FAQs

What is Quince Therapeutics Inc share price today?

Quince Therapeutics Inc share price today is $0.1 as on March 14, 2026 at 1:29 am IST at the close of the market. Quince Therapeutics Inc share today touched a day high of $0.11 and a low of $0.1.

What is the 52 week high and 52 week low for Quince Therapeutics Inc share?

Quince Therapeutics Inc share touched a 52 week high of $4.55 on December 12, 2025 and a 52 week low of $0.09 on March 3, 2026. Quince Therapeutics Inc stock price today i.e. March 14, 2026 at 1:29 am IST is closed at $0.1,which is 97.80% down from its 52 week high and 13.64% up from its 52 week low.

What is Quince Therapeutics Inc's market capitalisation today?

Quince Therapeutics Inc market capitalisation is $0.00T as on March 14, 2026 at 1:29 am IST.

How to invest in Quince Therapeutics Inc Stock (QNCX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Quince Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Quince Therapeutics Inc Shares that will get you 15.0000 shares as per Quince Therapeutics Inc share price of $0.1 per share as on March 14, 2026 at 1:29 am IST.

What is the minimum amount required to buy Quince Therapeutics Inc Stock (QNCX) from India?

Indian investors can start investing in Quince Therapeutics Inc (QNCX) shares with as little as ₹92.335 or $1 (as of March 16, 2026 at 5:43 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹923.35 in Quince Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on March 16, 2026 at 5:43 pm IST). Based on Quince Therapeutics Inc share’s latest price of $0.1 as on March 14, 2026 at 1:29 am IST, you will get 100.0000 shares of Quince Therapeutics Inc. Learn more about fractional shares .